Dew..you mentioned FMI would never direct anybody to PPHM trials..
Of course not....they'd have to be independent and non-biased to do that, wouldn't they? for cryin' out loud...
Media Release Basel, 12 January 2015 Roche enters a broad strategic collaboration with Foundation Medicine in the field of molecular information in oncology Collaboration leverages both companies’ strengths to advance the progress of personalized treatments for patients with cancer Roche to acquire a majority interest in Foundation Medicine (FMI) of up to 56.3% on a fully diluted basis through a tender and acquisition of newly issued shares. Roche will tender for approximately 15.6 million Foundation Medicine shares at USD 50 per share with an aggregate tender value of approximately USD 780 million. Roche will also invest USD 250 million in Foundation Medicine by acquiring 5 million newly issued shares at USD 50 per share.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.